A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients

• Status: Completed
• Trial end date: 2006-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The main goal of this study is to determine whether the American Heart Association-recommended fish oil dose is efficacious, safe, and tolerable in hemodialysis patients. The secondary objective is to test the effects of fish oil supplementation on inflammatory and cardiovascular markers.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Indiana University School of Medicine

Criteria

Exclusion Criteria:

1. Age <18

2. Pregnant individuals

3. Fish oil or omega-3 supplementation in past 6 months

4. Fish, corn, soybean, gelatin, or vanilla allergies

5. Currently enrolled in a dietary or investigational drug study

6. Life expectancy < 3 months

7. Ongoing active illness requiring hospitalization

8. Malabsorption syndromes

9. Chronic heparin or coumadin anticoagulation (??)

10. Active bleeding issues